Literature DB >> 25242140

Subclinical hypothyroidism as an independent risk factor for colorectal neoplasm.

Guifang Mu1, Xuefeng Mu2, Huizhi Xing3, Ruibiao Xu1, Guangxi Sun1, Chonghai Dong1, Qichuan Pan4, Chao Xu5.   

Abstract

BACKGROUND AND
OBJECTIVE: Recently, the prevalence of colorectal neoplasm is increasing sharply. It has been reported that both colorectal neoplasm and cardiovascular disease share similar common risk factors. Subclinical hypothyroidism (SCH) occurs in 4-20% of the adult population and is an independent risk factor for cardiovascular disease. However, no study has yet explored the relationship between SCH and colorectal neoplasm. Our objectives were to clarify the association between the two conditions.
METHODS: This is a case-control study. A total of 273 cases of colorectal neoplasm were first identified, and a 1:3 matched random sample of 819 controls was then collected using strata according to age, and gender. The medical records of all these patients were retrieved. Blood pressure, body mass index, and thyroid function were determined. Colonoscopies were performed by experienced gastroenterologists. A logistic regression analysis was carried out to explore the relationship between SCH and colorectal neoplasm.
RESULTS: Remarkably, the prevalence rate of SCH was significantly higher in colorectal neoplasm (+) group, compared with colorectal neoplasm (-) group (P<0.01). Colorectal neoplasm was found in 67 (34.9%) subjects in SCH group, which was more than that in euthyroid group (P=0.002). Moreover, patients with SCH were more likely to have advanced colonic lesion and colorectal cancer compared with euthyroid subjects (P=0.028 and 0.036, respectively). After adjusting for the factors of blood pressure, body mass index, history of hypertension and smoking, an association still existed between colorectal neoplasm and SCH (OR=1.689, 95% CI: 1.207-2.362, P=0.002).
CONCLUSION: A strong association between SCH and colorectal neoplasm was firstly identified. SCH was found to be an independent risk factor for colorectal neoplasm.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25242140     DOI: 10.1016/j.clinre.2014.08.002

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  6 in total

Review 1.  The Clinical Relevance of Hypothyroidism in Patients with Solid Non-Thyroid Cancer: A Tantalizing Conundrum.

Authors:  Maria V Deligiorgi; Dimitrios T Trafalis
Journal:  J Clin Med       Date:  2022-06-14       Impact factor: 4.964

Review 2.  Paradoxical roles of dual oxidases in cancer biology.

Authors:  Andrew C Little; Arvis Sulovari; Karamatullah Danyal; David E Heppner; David J Seward; Albert van der Vliet
Journal:  Free Radic Biol Med       Date:  2017-05-31       Impact factor: 7.376

Review 3.  DUOX1 in mammalian disease pathophysiology.

Authors:  Nuha Milad Ashtiwi; Demba Sarr; Balázs Rada
Journal:  J Mol Med (Berl)       Date:  2021-03-11       Impact factor: 4.599

4.  Malignant neoplasms in people with hypothyroidism in Spain: A population-based analysis.

Authors:  Juan J Díez; Pedro Iglesias
Journal:  PLoS One       Date:  2022-10-05       Impact factor: 3.752

5.  Hypothyroidism is associated with worse outcomes of hepatocellular carcinoma patients after liver transplantation.

Authors:  Ning Zhang; Weidong Jin; Shuangnan Zhou; Ju Dong Yang; William S Harmsen; Nasra H Giama; Nicha Wongjarupong; Julie K Heimbach; Kymberly D Watt; Harmeet Malhi; Terry M Therneau; Lewis R Roberts
Journal:  Cancer Med       Date:  2018-11-19       Impact factor: 4.452

6.  Subclinical hypothyroidism and the risk of cancer incidence and cancer mortality: a systematic review.

Authors:  Juan Gómez-Izquierdo; Kristian B Filion; Jean-Franҫois Boivin; Laurent Azoulay; Michael Pollak; Oriana Hoi Yun Yu
Journal:  BMC Endocr Disord       Date:  2020-06-09       Impact factor: 2.763

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.